Saturday, October 31, 2026

Aspen Group Stock Soars 21% In 5 Sessions: Is It A Bullish Momentum?

ViaNews Editorial Team

February 26, 2024

Aspen Group Stock Soars 21% In 5 Sessions: Is It A Bullish Momentum?

(VIANEWS) - Aspen Group (NASDAQ: ASPU) experienced a dramatic upswing in its stock price during the past five trading sessions. Shares surged 21.74% from EUR0.17 at 21.74 to EUR0.21 at 08:23 EST on Monday morning - marking a strong turnaround after two straight losses on NASDAQ. Despite an overall decrease of 0.28% to EUR15,996.82 overall market decline, Aspen Group managed to buck that trend and achieved its last closing price at EUR0.21, representing 17.35% discounting from its 52 week peak price of EUR0.26 high point.

About Aspen Group

Aspen Group, Inc. is an education technology company headquartered in New York City and providing online higher education services since 1987. They offer undergraduate, master's, and doctoral degree programs across nursing and health sciences disciplines; business/technology; arts & sciences/education fields through Aspen University and United States University respectively. As of April 30 2022 they had 13,334 degree-seekers enrolled.

Yearly Analysis

Yearly Top and Bottom Value (as of 8:27 EST): Aspen Group's stock currently trades at EUR0.21, which is significantly below its 52-week high of EUR0.26 but higher than its low of EUR0.03. Anticipated Sales Growth (as of Analysis Date): Aspen Group's expected sales growth this year and next is predicted to be negative -16.4% and -16.2%, indicating a decrease in revenue for their company.

Technical Analysis

Aspen Group stock has experienced a bullish trend in the market, as evidenced by its current price being significantly above both its 50-day and 200-day moving averages of EUR0.18 and EUR0.16, indicating an upward momentum over both short- and long-term periods. It should be noted, however, that today's volume was lower than its average volume of 31,271, suggesting a lack of conviction from investors. Aspen Group's intraday variation average has been relatively low over the last week, month and quarter with variations averaging 6.27%, 1.09% and 5.39% respectively; however it should be noted that its highest weekly amplitude of average volatility reached 16.54%; this could suggest that Aspen Group could be due for a correction. Asper Group's stock is currently considered overbought (>=80), signaling that investors could see its price return to normal or they may take this as an opportunity to take profits or wait for better entry points into its shares. Overall, Aspen Group stock is currently on an upswing; however, investors should remain wary of overbought conditions and potential for correction.

Quarter Analysis

Aspen Group's sales growth for both the current quarter (-24%) and next quarter (-29.3%) is negative, which indicates a decrease in sales which could be attributable to factors such as consumer behavior or market conditions. Year-on-year revenue growth has dropped 19% compared to the same quarter last year, which indicates a decrease in revenue compared to that same timeframe last year. Current twelve trailing months revenue stands at 58.83M; this suggests the company may be facing difficulty keeping pace with revenue increases over time and may need assistance maintaining its revenue stream.

Equity Analysis

Investment Outlook According to Aspen Group's financial data, its trailing twelve month EPS stands at EUR-0.38, representing negative earnings. Furthermore, its return on equity for these twelve trailing months stands at -12.95% - suggesting the company is operating at an operating loss and not producing profits for shareholders. Potential investors should therefore proceed with caution and conduct further due diligence prior to making investment decisions in Aspen Group.

More news about Aspen Group (ASPU).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com